An Evolving Treatment Landscape for Inflammatory Disease: Debating Interchangeability, Efficacy, and Safety of Biosimilars

A significant gap exists in awareness and knowledge amongst health care providers on the topic of biosimilars, creating perceived barriers within clinical practices. It’s imperative that clinicians are well-versed on the data surrounding interchangeability, safety, and efficacy of biosimilar agents so that they may confidently select the optimal treatment plan for their patients. In this CME Outfitters On Demand activity, real patient responses are at the center of the conversation, with expert faculty highlight the patients’ concerns while engaging in an evidence-based discussion on a variety of aspects of biosimilars.